Recent Finacing
Recent Raise
Photys Therapeutics develops phosphorylation-inducing chimeric small-molecule therapeutics (PHICS) that recruit kinases to modulate protein phosphorylation and function for cancer, immune, metabolic, and rare disease targets.
